logo
Select company
Select metric
33.05Enterprise Value over Free Cash Flow
VS
Market
30
Sector
34
Industry
31
History
50
$ 7.21Close
$ 3.43 - $ 14.41 52-Week Range
Ticker Information

Ticker

NAGE

Company Name

NIAGEN BIOSCIENCE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NIAGEN BIOSCIENCE INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NAGE - EV/FCF Historical data
DateEnterprise ValueEnterprise Value over Free Cash FlowFree Cash Flow
6/30/2025$ 692.5M33.05$ 20.95M
3/31/2025$ 613.51M31.36$ 19.56M
12/31/2024$ 393.39M32.88$ 11.97M
9/30/2024$ 237.07M58.11$ 4.08M
6/30/2024$ 174.94M179.25$ 976K
3/31/2024$ 264.97M58.53$ 4.53M
12/31/2023$ 106.99M15.34$ 6.97M
9/30/2023$ 97.22M16.63$ 5.85M
6/30/2023$ 101.34M60.18$ 1.68M
3/31/2023$ 91.15M0$ -5.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NIAGEN BIOSCIENCE INC's latest trailing twelve months (TTM) EV/FCF stands at 0.
  • Over the past 5 years, NIAGEN BIOSCIENCE INC's average EV/FCF has been 53.92.
  • The median EV/FCF for NIAGEN BIOSCIENCE INC during this period was 33.05
  • NIAGEN BIOSCIENCE INC reached its highest EV/FCF over the past 5 years at 179.25.
  • The lowest EV/FCF recorded by NIAGEN BIOSCIENCE INC in the same timeframe 15.34

NIAGEN BIOSCIENCE INC's EV/FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/FCF Benchmarks
CompanyEV/FCF
CRMD : CORMEDIX INC 21.31PHAT : PHATHOM PHARMACEUTICALS INC -GYRE : GYRE THERAPEUTICS INC 8.82KANAB : ANAPTYSBIO INC -ZYME : ZYMEWORKS INC -URGN : UROGEN PHARMA LTD -NRIX : NURIX THERAPEUTICS INC -TBPH : THERAVANCE BIOPHARMA INC 1.59SNDX : SYNDAX PHARMACEUTICALS INC -XNCR : XENCOR INC -

Definition of Enterprise Value over Free Cash Flow

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
EV / FCF
(=) EV/FCF
EV/FCF for NIAGEN BIOSCIENCE INC is calculated as follows: EV [ $ 281.69M ] / FCF [ $ -11.66M ]
(=) EV/FCF [ 0 ]

NAGE - Enterprise Value over Free Cash Flow, Last 5 years

15.34

Minimum

Dec 31, 2023

179.25

Maximum

Jun 30, 2024

53.92

Average

33.05

Median

EV/FCF Benchmark Analysis

The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.46 with a standard deviation of 16.15.
The following table provides additional summary stats:
EV/FCF in the Market:
filtered constituents2.2K
min0.05
max77.98
average23.46
median19.08
std16.15